newsfilter
← Latest News
FDA Approved Drugs·

Approval of Nuzolvence, Nda #219491 (Type 1 - New Molecular Entity)

Approval Date: 12/12/2025; Drug Name: Nuzolvence, Nda #219491; Active Ingredients: ZOLIFLODACIN; Company: Entasis Therap; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 219491

Company
ENTASIS THERAP
Keywords
ENTASIS THERAP